These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Priming with ceramide-1 phosphate promotes the therapeutic effect of mesenchymal stem/stromal cells on pulmonary artery hypertension. Lim J; Kim Y; Heo J; Kim KH; Lee S; Lee SW; Kim K; Kim IG; Shin DM Biochem Biophys Res Commun; 2016 Apr; 473(1):35-41. PubMed ID: 26993164 [TBL] [Abstract][Full Text] [Related]
26. Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension? Willis GR; Fernandez-Gonzalez A; Reis M; Mitsialis SA; Kourembanas S Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150544 [TBL] [Abstract][Full Text] [Related]
27. Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension. Farkas L; Kolb M Respiration; 2013; 85(5):355-64. PubMed ID: 23594605 [TBL] [Abstract][Full Text] [Related]
28. Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension. Goel K; Egersdorf N; Gill A; Cao D; Collum SD; Jyothula SS; Huang HJ; Sauler M; Lee PJ; Majka S; Karmouty-Quintana H; Petrache I Respir Res; 2022 Dec; 23(1):349. PubMed ID: 36522710 [TBL] [Abstract][Full Text] [Related]
29. Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention. Qiao L; Xie L; Shi K; Zhou T; Hua Y; Liu H PLoS One; 2012; 7(12):e51514. PubMed ID: 23251561 [TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling. Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495 [TBL] [Abstract][Full Text] [Related]
31. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension. Luan Y; Zhang ZH; Wei DE; Zhao JJ; Kong F; Cheng GH; Wang YB Am J Med Sci; 2012 May; 343(5):402-6. PubMed ID: 21876426 [TBL] [Abstract][Full Text] [Related]
32. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Pugliese SC; Poth JM; Fini MA; Olschewski A; El Kasmi KC; Stenmark KR Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L229-52. PubMed ID: 25416383 [TBL] [Abstract][Full Text] [Related]
33. [Effects of exosomes from human adipose-derived mesenchymal stem cells on pulmonary vascular endothelial cells injury in septic mice and its mechanism]. Cai WX; Shen K; Cao T; Wang J; Zhao M; Wang KJ; Zhang Y; Han JT; Hu DH; Tao K Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Mar; 38(3):266-275. PubMed ID: 35325972 [No Abstract] [Full Text] [Related]
34. [The effect of bone marrow mesenchymal stem cell transplantation on hypoxic pulmonary hypertension in rats]. Tian HJ; Yang JP; Wang XX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 May; 30(3):233-6. PubMed ID: 25244789 [TBL] [Abstract][Full Text] [Related]
35. Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells. Wang J; Liu W; Lu W; Luo X; Lin Y; Liu S; Qian J; Zhang C; Chen H; Li Y; Li X; Chen J; Chen Y; Jiang Q; Liu C; Hong C; Wang T; Tang H; Zhong N; Yang J; Yang K; Sun D Biochem Pharmacol; 2022 May; 199():114986. PubMed ID: 35276216 [TBL] [Abstract][Full Text] [Related]
36. Application of modified mesenchymal stem cells transplantation in the treatment of liver injury. Liu L; Yang F Physiol Res; 2021 Jul; 70(3):327-343. PubMed ID: 33982583 [TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells for therapeutic applications in pulmonary medicine. Stabler CT; Lecht S; Lazarovici P; Lelkes PI Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231 [TBL] [Abstract][Full Text] [Related]
39. Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension. Zeng C; Wang X; Hu X; Chen J; Wang L Med Hypotheses; 2007; 68(6):1292-5. PubMed ID: 17140742 [TBL] [Abstract][Full Text] [Related]
40. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway. Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]